loader2
Login Open ICICI 3-in-1 Account

Dec 05, 2025

loader2

Open ICICI 3-in-1 Account

Manage your Savings, Demat and Trading Account conveniently at one place

What is Nifty 200?

Company Name PE Mcap/Sales P/BV EV/EBIDTA D/E ROCE ROE
Abbott India Ltd 40.60 9.50 15.28 39.62 0.04 44.95 35.66
Cipla Ltd 22.61 4.46 3.73 17.56 0.02 23.15 18.28
J B Chemicals & Pharmaceuticals Ltd 39.75 7.29 7.50 28.32 0.06 26.42 20.75
Dr Reddys Laboratories Ltd 18.58 3.27 2.96 13.11 0.11 23.05 18.53
Lupin Ltd 21.98 4.21 4.87 18.46 0.27 20.88 21.00
Torrent Pharmaceuticals Ltd 60.12 11.17 15.20 39.97 0.50 25.84 26.46
Ipca Laboratories Ltd 43.30 4.14 4.97 25.21 0.21 17.12 13.61
Sun Pharmaceutical Industries Ltd 41.62 8.30 5.61 28.29 0.04 19.52 16.16
Aurobindo Pharma Ltd 20.78 2.24 2.03 11.71 0.24 14.16 11.15
Wockhardt Ltd -424.00 7.18 4.74 76.67 0.57 3.87 -1.48
Ajanta Pharma Ltd 33.70 7.06 7.61 25.61 0.01 31.98 25.02
Gland Pharma Ltd 36.08 5.08 2.99 19.09 0.00 15.83 11.62
Biocon Ltd 68.11 3.40 1.94 19.42 0.84 6.86 6.90
Alkem Laboratories Ltd 27.84 5.18 5.07 27.61 0.13 20.03 19.88
Glenmark Pharmaceuticals Ltd 55.17 4.18 5.81 31.46 0.22 18.48 15.79
Zydus Lifesciences Ltd 18.71 4.05 3.72 12.97 0.09 24.56 21.08
Divis Laboratories Ltd 69.12 18.35 11.14 57.01 0.00 20.42 15.35
Mankind Pharma Ltd 51.39 7.47 5.96 33.88 0.37 16.04 14.83
Laurus Labs Ltd 80.18 9.84 11.39 55.86 0.62 8.80 7.36
Piramal Pharma Ltd -1,003.06 2.62 2.98 23.86 0.60 6.43 1.14

Other Indices

INDEX NAME MARKET VALUE 52W HIGH 52W LOW
Nifty Next 50 68286.25
(-0.4004%)
73443.90 56192.45
Nifty Bank 59355.85
(0.1133%)
60114.30 47702.90
Nifty 50 26054.65
(0.0803%)
26325.80 21743.65
Nifty 100 26557.70
(0.0026%)
26859.50 22177.35
BSE SmallCap 51043.68
(-0.7683%)
57827.69 41013.68
BSE Sensex 85262.99
(-0.0027%)
86159.02 71425.01
BSE MidCap 46373.82
(-0.3188%)
48264.25 37203.21
BSE 100 27224.41
(-0.0596%)
27539.85 22539.11

Nifty Pharma

The NIFTY Pharma Index reflects the behaviour and performance of the pharmaceutical sector in India. The index has a maximum of 20 stocks since the last amendment effective from 30th September 2021. The NIFTY Pharma stocks are calculated using the free-float market capitalization method and can be used for benchmarking fund portfolios, among other utilization for investors. The index was launched in July 2005; the base date being 1st January 2001 with a base value of 1000. Index is re-balanced on semi-annual basis. The cut-off date is January 31 and July 31 of each year. When rebalancing, the weightage of each stock in the index is calculated such that no single stock has a weightage of more than 33%, and that of top 3 stocks cumulatively shall not be more than 62%.

News

Deccan Gold Mines fixes record date for rights issue

Deccan Gold Mines has fixed 09 December 2025 as record date for rights issue. Cap...

Dec 03, 2025 17:42
NSE revamps Nifty Bank and Financial Indices to meet SEBI`s derivatives norms

NSE Indices has rolled out a major overhaul of how some of India`s most traded sectoral indices are const...

Dec 02, 2025 11:38
Hindustan Construction Company fixes record date for rights issue

Hindustan Construction Company has fixed 05 December 2025 as record date for determining the shareholders...

Dec 02, 2025 09:49
Nureca fixes record date for buyback of shares

Nureca has fixed 12 December 2025 as record date for buyback of equity shares. Ca...

Nov 28, 2025 09:19
Marsons fixes record date for interim dividend

Marsons has fixed 01 December 2025 as record date for ascertaining the name of the members / beneficial ...

Nov 27, 2025 15:36
SEBI pushes for REIT inclusion in equity indices

SEBI chairperson Tuhin Kanta Pandey said the regulator is working to bring REITs into major equity indice...

Nov 22, 2025 10:27
Disclaimer

ICICI Securities Ltd.( I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Mumbai - 400025, India, Tel No:- 022 - 2288 2460, 022 - 2288 2470. I-Sec is a Member of National Stock Exchange of India Ltd (Member Code:-07730) and BSE Ltd (Member Code :103) and having SEBI registration no. INZ000183631. SEBI research analyst Registration no.-INH000000990. Name of the Compliance officer (broking): Mr. Anoop Goyal, Contact number: 022-40701000, E-mail address: complianceofficer@icicisecurities.com. Investment in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein above shall not be considered as an invitation or persuasion to trade or invest.  I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. The non-broking products / services like Mutual Funds, Insurance, FD/ Bonds, loans, PMS, Tax, Elocker, NPS, IPO, Research, Financial Learning etc. are not exchange traded products / services and ICICI Securities Ltd. is just acting as a distributor/ referral Agent of such products / services and all disputes with respect to the distribution activity would not have access to Exchange investor redressal or Arbitration mechanism.